300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Mobile
Oil and Gas
Payments
Retail
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Medical Device
Sports
Wellness
Education
Biotechnology
Legal
Automotive
Renewable Energy
eSports
Facebook
Software
Blockchain
Theatre
Medical
Web3
Beauty
Recruiting
Celebrity
Cannabis
Fashion
LGBT
Climate
Infrastructure
Food and Beverage
Life Science
Publishing
Wine and Spirits
Social
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Tunisia
Taiwan
Zimbabwe
Oman
Puerto Rico
Poland
Guernsey
Cameroon
China
Colombia
Armenia
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
New Zealand
Seychelles
Paraguay
Botswana
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Honduras
Lithuania
Cambodia
Israel
Iceland
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Aberdeen, VC Fund

Aberdeen

VC Fund

Edinburgh, United Kingdom

Aberdeen is a VC fund in Edinburgh focused on Financial Services and Biotechnology. Abrdn enables its clients to plan, save, and invest for their futures. Abrdn is operating across three vectors that reflect how their clients interact with them. Abrdn has the full ecosystem of capabilities to enable our clients to be better investors.

Total investments:
19
Last investment:
Lead investor:
26%
Last fund:

Last updated:

Industries Aberdeen invests in

Financial ServicesBiotechnologySoftwareFinTechMedical

Stages Aberdeen invests in

Series BPrivate EquitySeries AFunding RoundPost-IPO Debt

Countries Aberdeen invests in

United StatesUnited KingdomIndiaCanadaFinland

Contacts

NameEmailPhoneSocials
Alan R. Goodson
Barry Fricke Barry Fricke
Gershon Cohen Gershon Cohen
James Hathway James Hathway
Jonathan Asquith Jonathan Asquith
See all 10 contacts →

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Financial Services 5 (26%)
  • Biotechnology 4 (21%)
  • Software 3 (16%)
  • FinTech 2 (11%)
  • Medical 2 (11%)
See all 37 industries →

Stage

  • Series B 4 (21%)
  • Private Equity 4 (21%)
  • Series A 3 (16%)
  • Funding Round 2 (11%)
  • Post-IPO Debt 1 (5%)
See all 9 stages →

Country

  • United States 6 (32%)
  • United Kingdom 6 (32%)
  • India 1 (5%)
  • Canada 1 (5%)
  • Finland 1 (5%)
See all 7 countries →

Team

NameTitleInvestmentsLinksEmail
Alan R. Goodson Head of Product & Client Solutions - Americas
Head of Product & Client Solutions - Americas Total investments: 0
Find email
Barry Fricke
Barry Fricke Private Markets - Global Head of Product, Investment Specialists & Client Solutions
Private Markets - Global Head of Product, Investment Specialists & Client Solutions Total investments: 0
Find email
Gershon Cohen
Gershon Cohen Global Head of Infrastructure Funds
Global Head of Infrastructure Funds Total investments: 0
Find email
James Hathway
James Hathway Enterprise Architect
Enterprise Architect Total investments: 0
Find email
Jonathan Asquith
Jonathan Asquith Senior Independent Director
Senior Independent Director Total investments: 0
Find email
See all 10 team members →

Investments

CompanyDescriptionRoundLinks
FNZ FNZ
FNZ is a FinTech firm that partners with financial institutions to enable them to provide multi-channel wealth management services to their clients across direct, intermediated, and workplace channels. FNZ develops long-term partnerships with customers to enable them to get to market with a market-leading digital proposition, transform theircustomer service offering, and grow assets under management across multiple distribution channels. $650M / Private Equity / Nov 12, 2025
Atalanta Therapeutics Atalanta Therapeutics
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing its proprietary RNA interference platform. $97M / Series B / Jan 28, 2025
Radiant Biotherapeutics Radiant Biotherapeutics
Radiant Biotherapeutics is a revolutionary antibody platform company leading the new frontier of multi-valent, multi-specific therapeutics to deliver transformative therapies for patients. $35M / Series A / Sep 11, 2024
Qlaris Bio Qlaris Bio
Qlaris Bio focuses on developing novel and innovative therapies for serious and debilitating ophthalmic diseases. Qlaris Bio is a spinout company of Qrativ, a biotechnology incubator formed as a joint venture between Mayo Clinic and inference, a pharmaceutical-focused artificial intelligence company. Its lead program is QLS-101, a novel compoundinvented at Mayo Clinic and the University of Minnesota. QLS-101, with its unique and first-in-class mechanism of action, may potentially serve as an efficacious treatment for high unmet need conditions related to disturbances in intraocular pressure, including a sight-threatening and progressive Pediatric Rare Disease for which effective therapies remain elusive and limited.Qlaris Bio was founded in 2019 and is headquartered in Cambridge, Massachusetts. $24M / Series B / Apr 22, 2024
Sammaan Capital Sammaan Capital
Sammaan Capital offers loans such as home loans, home loans for NRIs, and loans against properties at affordable interest rates for salaried and self-employed individuals within a shorter period. The company is based in India and it was founded in 2000. $347.9M / Post-IPO Debt / Mar 27, 2024
Engrail Therapeutics Engrail Therapeutics
Engrail is forging a new direction to reduce the enormous burden of diseases that impact the nervous system. We unite biological insights with clinically meaningful solutions to build and catalyze a diversified portfolio of transformative medicines. Harnessing our rigorous scientific approach to identify the most promising therapies, we leverageour flexible transaction model to advance assets with validated mechanisms and efficiently move them through development to commercialization. $157M / Series B / Mar 19, 2024
Etelä-Savon Energia Etelä-Savon Energia
Etelä-Savon Energia produces light,heat and energy savings. Private Equity / Nov 06, 2023
Etelä-Savon Energia Etelä-Savon Energia
Etelä-Savon Energia produces light,heat and energy savings. Private Equity / Nov 06, 2023
Eagle Genomics Eagle Genomics
Eagle Genomics is a enterprise software solutions company whose products enable the management, orchestration and exploitation of genomics and other life sciences data. They help Life Science companies get the maximum value from their R&D data and they are delivering the information architecture for the genomics era. Their suite of softwareproducts radically reduces cost and time to complete research, enabling drastic productivity improvements.Their architecture translates data sets into data assets, redefining the current paradigm in the industry, enabling the objective measurement of the value of digital assets and providing clarity on “return on information”. Their mix of expertise in biology, bioinformatics, data science and enterprise-class software engineering is unique in the field and has been applied over the last decade to solve their customers’ challenges in areas as diverse as drug development, personal hygiene and plant breeding.With global customers in the pharmaceuticals, fast moving consumer goods and agri-tech industries they understand the common challenges facing these industries in the handling of ever growing of data and information resources. Eagle Genomics is at the forefront in addressing the challenges, risks, and opportunities in delivering the enterprise information architecture for the genomics era. $3.6M / Venture - Series Unknown / Sep 27, 2023
Trinity Gas Storage Trinity Gas Storage
Trinity Gas Storage offers tailored gas storage services to meet the needs of a wide range of potential gas storage customers. Private Equity / Sep 11, 2023
See all 19 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Mobile
Oil and Gas
Payments
Retail
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Medical Device
Sports
Wellness
Education
Biotechnology
Legal
Automotive
Renewable Energy
eSports
Facebook
Software
Blockchain
Theatre
Medical
Web3
Beauty
Recruiting
Celebrity
Cannabis
Fashion
LGBT
Climate
Infrastructure
Food and Beverage
Life Science
Publishing
Wine and Spirits
Social
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Tunisia
Taiwan
Zimbabwe
Oman
Puerto Rico
Poland
Guernsey
Cameroon
China
Colombia
Armenia
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
New Zealand
Seychelles
Paraguay
Botswana
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Honduras
Lithuania
Cambodia
Israel
Iceland
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Aberdeen invest in?

Aberdeen invests primarily in Financial Services, Biotechnology and Software startups, most often at Series B and Private Equity stage. Most of the 19 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Aberdeen?

Public channels for Aberdeen include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Aberdeen?

The team at Aberdeen includes Alan R. Goodson (Head of Product & Client Solutions - Americas), Barry Fricke (Private Markets - Global Head of Product, Investment Specialists & Client Solutions) and Gershon Cohen (Global Head of Infrastructure Funds), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Aberdeen Aberdeen Find emails